bergen13ga10.htm

0000892251-08-000027.txt : 20080213 0000892251-08-000027.hdr.sgml : 20080213 20080213162116 ACCESSION NUMBER: 0000892251-08-000027 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20080213 DATE AS OF CHANGE: 20080213 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: KENDLE INTERNATIONAL INC CENTRAL INDEX KEY: 0001039151 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 311274091 STATE OF INCORPORATION: OH FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-52911 FILM NUMBER: 08605086 BUSINESS ADDRESS: STREET 1: 441 VINE ST STREET 2: STE 1200 CITY: CINCINNATI STATE: OH ZIP: 45202 BUSINESS PHONE: 5137631414 MAIL ADDRESS: STREET 1: 1200 CAREW TOWER STREET 2: 441 VINE STREET CITY: CINCINNATI STATE: OH ZIP: 45202 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BERGEN CHRISTOPHER C CENTRAL INDEX KEY: 0001055100 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] STATE OF INCORPORATION: OH FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 441 VINE ST STREET 2: STE 700 CITY: CINCINNATI STATE: OH ZIP: 45202 BUSINESS PHONE: 5137631414 MAIL ADDRESS: STREET 1: KENDLE INTERNATIONAL INC. STREET 2: 1200 CAREW TOWER, 441 VINE STREET CITY: CINCINNATI STATE: OH ZIP: 45202 SC 13G/A 1 bergen13ga10.htm CHRISTOPHER C. BERGEN SCHEDULE 13G AMENDMENT NO. 10 bergen13ga10.htm

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. 10)*

Kendle International Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

48880L 10 7

(CUSIP Number)

December 31, 2007

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

[ ] Rule 13d-1(b)

[ ] Rule 13d-1(c)

[ X ] Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

(Continued on following page(s))

CUSIP NO. 48880L 10 7

Page 2 of 4 Pages

1	NAME OF REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Christopher C. Bergen
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) o (b) x
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION United States of America
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5	SOLE VOTING POWER 672,311
	6	SHARED VOTING POWER 0
	7	SOLE DISPOSITIVE POWER 672,311
	8	SHARED DISPOSITIVE POWER 0
9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 672,311
10	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 4.6%
12	TYPE OF REPORTING PERSON* IN

Page 3 of 4 Pages

Item 1 (a) Name of Issuer: Kendle International Inc.

Item 1 (b) Address of Issuer's Principal Executive Office:

1200 Carew Tower

441 Vine Street

Cincinnati, Ohio 45202

Item 2 (a) Name of Person Filing: Christopher C. Bergen

Item 2 (b) Address of Principal Business Office:

1200 Carew Tower

441 Vine Street

Cincinnati, Ohio 45202

Item 2 (c) Citizenship: U.S.A.

Item 2 (d) Title of Class of Securities: Common Stock, No Par Value

Item 2 (e) CUSIP Number: 48880L 10 7

Item 3

If this Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b),check whether the Person Filing is a: N/A

Item 4

Ownership:

a) See Item 9 of cover page.

b) See Item 11 of cover page.

c) See Items 5-8 of cover page.

Shares numbers in Items 5, 7 and 9 include 17,300 shares for which Mr. Bergen holds options exercisable within 60 days, restricted stock awards in the amount of 9,500 shares of Common Stock, 239,040 shares pledged as collateral with U.S. Bank, and 4,000 shares held by the CCB Family Foundation, Inc. under which Mr. Bergen serves as sole trustee.

Beneficial ownership for Mr. Bergen does not include 832,442 shares of Common Stock beneficially owned by Dr. Kendle, Mr. Bergen’s wife.

Item 5

Ownership of 5% or Less of Class: If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: x

Item 6

Ownership of More Than 5% on Behalf of Another Person: N/A

Item 7

Identification and Classification of the Subsidiary which Acquired the Security being Reported on by the Parent Holding Company: N/A

Item 8 Identification and Classification of Members of the Group: N/A

Page 4 of 4 Pages

Item 9 Notice of Dissolution of Group: N/A

Item 10 Certification: N/A

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.




Date: February 13, 2008		/s/ Stacey Heiser

		Name: Stacey Heiser as Attorney-in-Fact for Christopher C. Bergen

EX-99.16 PWR OF ATTY 2 poa.htm CHRISTOPHER C. BERGEN POWER OF ATTORNEY poa.htm

POWER OF ATTORNEY

Know all by these presents, that the undersigned hereby constitutes and appoints each of Stacey Heiser, Jason Staples and F. Mark Reuter signing singly, the undersigned’s true and lawful attorney-in-fact to:

(1)

execute for and on behalf of the undersigned, Schedule 13D and 13G in accordance with Sections 13(d) and 13(g) of the Securities Exchange Act of 1934 and the rules thereunder.

(2)

do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Schedule 13D and 13G and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and

(3)

take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion including, but not limited to, executing and filing any and all amendments to Schedule 13D and 13G.

The undersigned hereby grants to such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorney-in-fact, in serving in such capacity at the request of the undersigned, are not assuming any of the undersigned’s responsibilities to comply with Sections 13(d) and 13(g) of the Securities Exchange Act of 1934.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Schedule 13D and 13G with respect to the undersigned’s holdings of and transactions in securities, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorney-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this th day of February, 2008.



		/s/ Christopher C. Bergen
		Christopher C. Bergen